Related Experiment Video
Updated: Aug 13, 2025

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
A Single-Center Experience With Kidney Transplantation in Patients Who Had Low Left Ventricular Ejection Fraction
Yucel Yuksel1,2, Ilker Tekin, Halil Erbis
1From the Department of General Surgery and Transplantation, Sanko University, Gaziantep, Turkey.
Insights
Kidney transplant improves heart function in patients with low ejection fraction. Left ventricular ejection fraction below 50% is not a contraindication for kidney transplant in end-stage renal disease patients.
Area of Science:
- Nephrology
- Cardiology
- Transplantation
Background:
- Left ventricular hypertrophy is common in end-stage renal disease.
- Low left ventricular ejection fraction (LVEF) impacts survival in heart failure.
- This study examines kidney transplant outcomes in patients with LVEF <50%.
Purpose of the Study:
- To evaluate the safety and efficacy of living donor kidney transplant in patients with pre-existing low left ventricular ejection fraction.
- To assess the impact of kidney transplantation on cardiac function and survival in this patient group.
Main Methods:
- Retrospective analysis of 31 living donor kidney transplant recipients with pretransplant LVEF <50% (Nov 2008-Nov 2021).
- Echocardiograms and New York Heart Association (NYHA) classification assessed pre- and post-transplant.
- Graft survival and patient mortality data were analyzed.
Main Results:
- Kidney transplant significantly improved NYHA classification (P = .001).
- Mean LVEF increased from 32% pre-transplant to 52% at 6 months post-transplant (P < .001).
- Graft loss and all-cause mortality rates were both 12.9%.
Conclusions:
- Low LVEF (<50%) is not an absolute contraindication for kidney transplantation.
- Myocardial scintigraphy is recommended for end-stage renal disease patients with low LVEF prior to transplant consideration.
- Kidney transplant can be a viable option for selected patients without ischemic heart disease.
Objectives:
Left ventricular hypertrophy is one of the most typical cardiac abnormalities detected in patients with end-stage renal disease. In patients with congestive heart failure, the most crucial factor determining patient survival is left ventricular ejection fraction. Herein, we present our experience with living donor kidney transplant recipients with a left ventricular ejection fraction of <50%.
Materials And Methods:
Patients who underwent living donor kidney transplant in our center between November 2008 and November 2021 and had pretransplant left ventricular ejection fraction <50% were included. All patients had dialysis the day before surgery. All patients underwent 2-dimensional echocardiograms after dialysis and were categorized according to New York Heart Association classification, pretransplant and on posttransplant day 5. Demographic parameters and additional data, including pretransplant and posttransplant day 5 New York Heart Association classification, left ventricular ejection fraction at 6 months, and graft survival at 6 months, as well as patient survival data, were analyzed.
Results:
Our study included 31 patients (mean age of 46.6 ± 18.3; range, 11-77 years). We found significant differences in New York Heart Association classifications before and after transplant, indicating that kidney transplant had a positive effect on pretransplant congestive heart failure in patients with low left ventricular ejection fraction (P = .001). The mean pretransplant left ventricular ejection fraction was 32 ± 9.9% (range, 1%-45%), whereas the mean 6-month posttransplant left ventricular ejection fraction was 52 ± 8.7% (range, 28%-63%) (P < .001). Both graft loss and all-cause mortality rates were 12.9%.
Conclusions:
Low left ventricular ejection fraction is not a contraindication for kidney transplant. We suggest that myocardial scintigraphy should be performed in patients with end-stage renal disease and low left ventricular ejection fraction, and kidney transplant should be considered in those without ischemic findings.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care

